Open this publication in new window or tab >> Department of Life Sciences, Centre of Genome Engineering and Maintenance, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom.
INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1317, Rennes, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Université Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.
The Rowett Institute, Foresterhill Health Campus, University of Aberdeen, Aberdeen, United Kingdom.
Seh Consulting + Services, Stembergring 15, Paderborn, Germany.
Institute for Risk Assessment Sciences, Department of Population Health Sciences, Utrecht University, Utrecht, Netherlands.
Radiation, Chemical and Environmental Hazards (RCE), Department of Toxicology, UK Health Security Agency (UKHSA), Harwell Science and Innovation Campus, Oxon, Chilton, United Kingdom.
Institute for Risk Assessment Sciences, Department of Population Health Sciences, Utrecht University, Utrecht, Netherlands.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
INRAE. UMR1331 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UT3, Toulouse, France.
Flemish Institute for Technological Research (VITO), Mol, Belgium.
Umeå University, Faculty of Science and Technology, Department of Chemistry.
INRAE. UMR1331 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UT3, Toulouse, France.
Institute for Risk Assessment Sciences, Department of Population Health Sciences, Utrecht University, Utrecht, Netherlands.
Radiation, Chemical and Environmental Hazards (RCE), Department of Toxicology, UK Health Security Agency (UKHSA), Harwell Science and Innovation Campus, Oxon, Chilton, United Kingdom.
French Agency for Food, Environmental and Occupational Health and Safety (Anses), Maisons-Alfort, France.
Show others...
2024 (English) In: Toxicology and Applied Pharmacology, ISSN 0041-008X, E-ISSN 1096-0333, Vol. 489, article id 116995Article in journal (Refereed) Published
Abstract [en] Identification of Endocrine-Disrupting Chemicals (EDCs) in a regulatory context requires a high level of evidence. However, lines of evidence (e.g. human, in vivo, in vitro or in silico) are heterogeneous and incomplete for quantifying evidence of the adverse effects and mechanisms involved. To date, for the regulatory appraisal of metabolism-disrupting chemicals (MDCs), no harmonised guidance to assess the weight of evidence has been developed at the EU or international level. To explore how to develop this, we applied a formal Expert Knowledge Elicitation (EKE) approach within the European GOLIATH project. EKE captures expert judgment in a quantitative manner and provides an estimate of uncertainty of the final opinion. As a proof of principle, we selected one suspected MDC -triphenyl phosphate (TPP) - based on its related adverse endpoints (obesity/adipogenicity) relevant to metabolic disruption and a putative Molecular Initiating Event (MIE): activation of peroxisome proliferator activated receptor gamma (PPARγ). We conducted a systematic literature review and assessed the quality of the lines of evidence with two independent groups of experts within GOLIATH, with the objective of categorising the metabolic disruption properties of TPP, by applying an EKE approach. Having followed the entire process separately, both groups arrived at the same conclusion, designating TPP as a “suspected MDC” with an overall quantitative agreement exceeding 85%, indicating robust reproducibility. The EKE method provides to be an important way to bring together scientists with diverse expertise and is recommended for future work in this area.
Place, publisher, year, edition, pages
Elsevier, 2024
Keywords Elicitation, Metabolism-disrupting chemicals, Obesity, PPARγ, Triphenyl phosphate (TPP), Weight of evidence
National Category
Pharmacology and Toxicology
Identifiers urn:nbn:se:umu:diva-227567 (URN) 10.1016/j.taap.2024.116995 (DOI) 38862081 (PubMedID) 2-s2.0-85196255433 (Scopus ID)
Funder EU, Horizon 2020, 825489
2024-07-022024-07-022024-07-02 Bibliographically approved